Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist. [electronic resource]
Producer: 19970611Description: 133-7 p. digitalISSN:- 0937-941X
- Adult
- Anthropometry
- Bone Density -- drug effects
- Calcium -- therapeutic use
- Drug Therapy, Combination
- Etidronic Acid -- therapeutic use
- Female
- Hirsutism -- drug therapy
- Humans
- Luteolytic Agents -- adverse effects
- Osteoporosis -- chemically induced
- Polycystic Ovary Syndrome -- drug therapy
- Triptorelin Pamoate -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.